CN107788451A - 一种供糖尿病患者食用的配方食品 - Google Patents
一种供糖尿病患者食用的配方食品 Download PDFInfo
- Publication number
- CN107788451A CN107788451A CN201710855446.6A CN201710855446A CN107788451A CN 107788451 A CN107788451 A CN 107788451A CN 201710855446 A CN201710855446 A CN 201710855446A CN 107788451 A CN107788451 A CN 107788451A
- Authority
- CN
- China
- Prior art keywords
- food
- vitamin
- parts
- formula food
- diabetes patients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 42
- 235000013305 food Nutrition 0.000 title claims abstract description 35
- 235000013312 flour Nutrition 0.000 claims abstract description 12
- 229920002752 Konjac Polymers 0.000 claims abstract description 11
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 9
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims abstract description 9
- 239000004375 Dextrin Substances 0.000 claims abstract description 7
- 229920001353 Dextrin Polymers 0.000 claims abstract description 7
- 235000019425 dextrin Nutrition 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 7
- 239000000796 flavoring agent Substances 0.000 claims abstract description 6
- 235000019634 flavors Nutrition 0.000 claims abstract description 6
- 235000013373 food additive Nutrition 0.000 claims abstract description 6
- 239000002778 food additive Substances 0.000 claims abstract description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 22
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 12
- 229930003451 Vitamin B1 Natural products 0.000 claims description 12
- 235000005152 nicotinamide Nutrition 0.000 claims description 12
- 239000011570 nicotinamide Substances 0.000 claims description 12
- 229960003966 nicotinamide Drugs 0.000 claims description 12
- 229960003495 thiamine Drugs 0.000 claims description 12
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 12
- 235000010374 vitamin B1 Nutrition 0.000 claims description 12
- 239000011691 vitamin B1 Substances 0.000 claims description 12
- 229930003779 Vitamin B12 Natural products 0.000 claims description 11
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 11
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 11
- 235000019163 vitamin B12 Nutrition 0.000 claims description 11
- 239000011715 vitamin B12 Substances 0.000 claims description 11
- 235000019158 vitamin B6 Nutrition 0.000 claims description 11
- 239000011726 vitamin B6 Substances 0.000 claims description 11
- 229940011671 vitamin b6 Drugs 0.000 claims description 11
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 9
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 9
- 239000000811 xylitol Substances 0.000 claims description 9
- 235000010447 xylitol Nutrition 0.000 claims description 9
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 9
- 229960002675 xylitol Drugs 0.000 claims description 9
- 241000209140 Triticum Species 0.000 claims description 8
- 235000021307 Triticum Nutrition 0.000 claims description 8
- 239000004376 Sucralose Substances 0.000 claims description 5
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 5
- 235000019408 sucralose Nutrition 0.000 claims description 5
- 230000004060 metabolic process Effects 0.000 abstract description 14
- 230000036541 health Effects 0.000 abstract description 8
- 235000015097 nutrients Nutrition 0.000 abstract description 8
- 235000012054 meals Nutrition 0.000 abstract description 7
- 230000036186 satiety Effects 0.000 abstract description 7
- 235000019627 satiety Nutrition 0.000 abstract description 7
- 230000037396 body weight Effects 0.000 abstract description 6
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 6
- 235000019789 appetite Nutrition 0.000 abstract description 5
- 230000036528 appetite Effects 0.000 abstract description 5
- 235000013325 dietary fiber Nutrition 0.000 abstract description 5
- 230000030136 gastric emptying Effects 0.000 abstract description 5
- 208000033808 peripheral neuropathy Diseases 0.000 abstract description 4
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 abstract description 3
- 102400000322 Glucagon-like peptide 1 Human genes 0.000 abstract description 3
- 101800000224 Glucagon-like peptide 1 Proteins 0.000 abstract description 3
- 230000002496 gastric effect Effects 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 229920001184 polypeptide Polymers 0.000 abstract description 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 3
- 239000003053 toxin Substances 0.000 abstract description 3
- 231100000765 toxin Toxicity 0.000 abstract description 3
- 229920002472 Starch Polymers 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 235000012631 food intake Nutrition 0.000 abstract description 2
- 230000007661 gastrointestinal function Effects 0.000 abstract description 2
- 230000007413 intestinal health Effects 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 235000019698 starch Nutrition 0.000 abstract description 2
- 239000008107 starch Substances 0.000 abstract description 2
- 239000011573 trace mineral Substances 0.000 abstract description 2
- 235000013619 trace mineral Nutrition 0.000 abstract description 2
- 235000019197 fats Nutrition 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 229940088594 vitamin Drugs 0.000 description 8
- 229930003231 vitamin Natural products 0.000 description 8
- 235000013343 vitamin Nutrition 0.000 description 8
- 239000011782 vitamin Substances 0.000 description 8
- RNBGYGVWRKECFJ-ZXXMMSQZSA-N alpha-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ZXXMMSQZSA-N 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 229940025237 fructose 1,6-diphosphate Drugs 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 230000037353 metabolic pathway Effects 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 230000007170 pathology Effects 0.000 description 6
- 230000002093 peripheral effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 4
- 102000040350 B family Human genes 0.000 description 4
- 108091072128 B family Proteins 0.000 description 4
- 229930091371 Fructose Natural products 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- 239000005715 Fructose Substances 0.000 description 4
- 229920002581 Glucomannan Polymers 0.000 description 4
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940046240 glucomannan Drugs 0.000 description 4
- 230000034659 glycolysis Effects 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000001228 trophic effect Effects 0.000 description 4
- 102000007584 Prealbumin Human genes 0.000 description 3
- 108010071690 Prealbumin Proteins 0.000 description 3
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 3
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 3
- 230000023852 carbohydrate metabolic process Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 3
- 102000016912 Aldehyde Reductase Human genes 0.000 description 2
- 108010053754 Aldehyde reductase Proteins 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 108010009384 L-Iditol 2-Dehydrogenase Proteins 0.000 description 2
- 102000004407 Lactalbumin Human genes 0.000 description 2
- 108090000942 Lactalbumin Proteins 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 102100026974 Sorbitol dehydrogenase Human genes 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- LFTYTUAZOPRMMI-CFRASDGPSA-N UDP-N-acetyl-alpha-D-glucosamine Chemical compound O1[C@H](CO)[C@@H](O)[C@H](O)[C@@H](NC(=O)C)[C@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-CFRASDGPSA-N 0.000 description 2
- LFTYTUAZOPRMMI-UHFFFAOYSA-N UNPD164450 Natural products O1C(CO)C(O)C(O)C(NC(=O)C)C1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-UHFFFAOYSA-N 0.000 description 2
- 235000021120 animal protein Nutrition 0.000 description 2
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 210000000578 peripheral nerve Anatomy 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- KLYCPFXDDDMZNQ-UHFFFAOYSA-N Benzyne Chemical compound C1=CC#CC=C1 KLYCPFXDDDMZNQ-UHFFFAOYSA-N 0.000 description 1
- 241000522254 Cassia Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 102000003793 Fructokinases Human genes 0.000 description 1
- 108090000156 Fructokinases Proteins 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010056997 Impaired fasting glucose Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000227425 Pieris rapae crucivora Species 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229950001485 cocarboxylase Drugs 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- -1 grape sugar polyol Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000001032 spinal nerve Anatomy 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/115—Konjak; Konntaku
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/37—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明公开供糖尿病患者食用的配方食品，包括8‑11份魔芋粉、40‑55份蛋白粉、24‑35份啤酒酵母、6‑12份抗性糊精和风味食品添加剂；本发明创新了食品的成分和配比，配方食品在饭前服用，可增加胰高血糖素样肽1和肠抑胃肽等肠道多肽的释放，延缓胃排空，增加饱腹感，降低食欲，控制体重；此外，本品丰富的膳食纤维和微量元素，加速脂肪代谢、排除肠道内的脂肪毒素，不仅可有助于维持胃肠道功能，也能够保证患者的营养平衡；有效地缓解糖尿病患者出现的周围神经病变；风味食品添加剂提升了食品食用时的体验，口感和味道都会改良；淀粉含量低、食用后饱腹感强、复合膳食同时有助于肠道健康的特点，有助于糖尿病患者的身体健康。
Description
技术领域
本发明属于特殊医学用途配方食品技术领域，尤其涉及一种供糖尿病患者食用的配方食品。
背景技术
随着现代医学的发展，传统疾病逐渐得到控制，但由于人们饮食结构的改变，我国慢性病逐年增加，慢病人口已接近3亿人，已成为我国重大的公共卫生问题。以糖尿病为例，我国糖尿病患病率高达 9.7％，北京市18至80岁常住居民的糖尿病患病率为8.6％，还有5.1％的空腹血糖受损人群。因此，政府十分重视，国务院连续出台了《关于促进健康服务业发展的若干意见》、《中国食物与营养发展纲要 2014-2020年》等文件，2014年卫生部部长陈竺指出“对于慢性病要发挥营养治疗的作用”，国家已将健康产业设定为我国未来发展的重要方向。
营养功能食品是健康产业的核心领域，既能满足人们不断增长的食品消费需求，又能满足人们的健康诉求，在我国属新兴产业，每年增速在30％以上，发展十分迅速。同时涌现了江中集团、新时代健康产业集团、完美有限公司等一批优秀企业，市场产品琳琅满目，但整体研究基础较为薄弱，产品质量良莠不齐，机制不明确，产品与发达国家相比还有较大差距。从人均消费水平来看，美国和澳洲分别为 56美元和41.6美元，国内市场仅为11.4美元，可见我国营养功能食品发展潜力之巨大、发展空间之广阔。
此外，我国营养功能食品产品极少呈现食品形态，基本为胶囊、丸剂、片剂等药品形态，难以起到日常饮食即可干预的作用效果。因此，开展国内营养功能产品的机理研究、产品创制和转型升级势之所迫，迫在眉睫。
现有技术中，为了解决上述技术问题，出现了大量的适于糖尿病患者食用的营养食品，例如申请公布号为CN101695376A的发明专利公开了一种预防糖尿病的保健食品，其按重量百分比的主要原料组成是：小麦面粉55-75％，荞麦面粉3-10％，大麦面粉3-10％，莜麦面粉3-10％，青稞面粉3-10％，牛蒡1-3％，赤小豆1-3％，山药2-4％，葛根2％-4％，肉桂0.5-1％，玉米须0.5-1％，灵芝0.5-1％，黄芩 0.5-1％，丹参0.8-1.5％，黄芪0.8-1.5％，黄精0.8-1.5％，茯苓0.8-1.5％，桑叶1-3％。该保健食品可为人体全面均衡地补充营养物质，增强免疫力，适合各类糖尿病患者食用。
但现有技术中的相关营养保健食品，其多含有中药提取物，遵从药食同源原理，因此其口感和味道仍有待提高，同时现有的适用于糖尿病患者食用的营养保健食品不能很好的配合唐脑病患者的情况，无法有效提供均衡营养，不能有效辅助糖尿病患者控制血糖。
并且在现有技术中，并没有针对性的对于糖尿病可能出现的其他病变进行预防。
综上所述，能否基于现有技术中的不足，提供一种原料组分改进的适于糖尿病患者食用的配方食品，使其具有使用方便，原料组分配伍合理，在不改变饮食习惯的前提下，可以提供的充足蛋白质，保证机体的蛋白需求，有效辅助糖尿病患者控制血糖，有效补充营养，延缓胃排空，增加饱腹感，降低食欲，控制体重、缓解糖尿病患者出现的周围神经病变的功能成为本领域技术人员亟待解决的技术问题。
发明内容
本发明要解决的技术问题在于，针对现有技术的加热系统存在的技术问题，本发明提供一种供糖尿病患者食用的配方食品，使用方便，原料组分配伍合理，在不改变饮食习惯的前提下，可以提供的充足蛋白质，保证机体的蛋白需求，有效辅助糖尿病患者控制血糖，有效补充营养，延缓胃排空，增加饱腹感，降低食欲，控制体重、缓解糖尿病患者出现的周围神经病变。
为了解决上述技术问题，本发明提供了一种供糖尿病患者食用的配方食品，其特征在于，包括8-11份魔芋粉、40-55份蛋白粉、24-35 份啤酒酵母、6-12份抗性糊精和风味食品添加剂。
进一步的，还包括维生素B1、维生素B6、维生素B12和烟酰胺。
进一步的，所述维生素B1、维生素B6、维生素B12和烟酰胺的分量分别为9-22mg/kg、7-22mg/kg、10-66mg/kg和110-330ug/kg。
进一步的，所述风味食品添加剂包括木糖醇、麦香香精和三氯蔗糖。
糖尿病神经病变是糖尿病主要的慢性并发症，其中以糖尿病周围神经病变最为常见。糖尿病周围神经病变是由于患者长期严重高血糖而导致的代谢障碍、微循环异常和自身免疫紊乱。常见的临床表现为肢体麻木、对称性下肢疼痛、刺痛甚至剧痛，部分患者出现单肢周围神经或脊神经分布区域剧烈疼痛。该病变严重影响了患者的生活质量，给患者带来巨大的痛苦。
糖尿病周围神经病变的确切发病机制尚不完全清楚，大量研究表明该病变的发生可能与糖代谢紊乱有关。糖代谢紊乱可能会通过两种方式造成周围神经产生病变：①糖尿病所处的高血糖会通过糖酵解途径产生大量的6-磷酸果糖，当6-磷酸果糖超过了糖酵解途径的代谢能力时，多余的6-磷酸果糖会代谢生成尿苷二磷酸-N-乙酰葡糖胺 (UDP-GlcNAc)，从而最终产生前白蛋白(PA-1)和转化生长因子β(TGF-β1)等炎症因子引起神经末梢炎症。②糖尿病所处的高血糖状态会激活葡萄糖的旁路代谢——多元醇代谢途径，促进葡萄糖依次通过醛糖还原酶(Aldose reductase,ALR)和山梨醇脱氢酶 (Sorbitoldehydrogenase,SDH)的催化作用生成果糖。该代谢途径会大量消耗NADPH，NADPH的消耗会导致NO合成减少或者谷胱甘肽减少，引起血管的血流量下降和大量自由基产生，造成神经损伤。
另外，由于神经组织内缺乏果糖激酶，无法代谢果糖，所以通过多元醇代谢途径产生的山梨醇和果糖会在细胞内堆积，引起细胞内的渗透压增高，最终造成神经细胞的肿胀和坏死。
糖尿病周围神经病变目前在临床上缺乏特异性的治疗方法，控制饮食和控制血糖是预防和治疗糖尿病周围神经病变的根本方法。同时大量研究表明，B1、B6、B12和烟酰胺等B族维生素可以有效地缓解糖尿病周围神经病变。①这些维生素是糖代谢的辅酶主要成分，可以促进血糖通过糖酵解途径进行代谢。②血糖在糖酵解途径中产生的 6-磷酸果糖，在B族维生素的作用下，可以转化为5-磷酸戊糖，最后通过磷酸戊糖代谢途径产生NADPH。该作用会消耗过剩的6-磷酸果糖，它不仅可以抑制6-磷酸果糖通过多元醇代谢途径生成山梨醇和果糖，维持细胞内的渗透压稳定，也可以减少6-磷酸果糖通过转化为 UDP-GlcNAc而产生PA-1和TGF-β1等炎症因子；同时它还可以补充葡萄糖多元醇代谢途径消耗的NADPH，缓解因其缺乏而引起的神经损伤。
本发明中的啤酒酵母富含1优质膳食纤维、完整的B族维生素、酵母铬和均衡营养素如蛋白质、维生素、矿物质、核酸等；优质膳食纤维具有抑制食欲、加速脂肪代谢、排除肠道内的脂肪毒素的作用； B族维生素能够加速脂肪代谢、快速消耗热量、促使毛发、皮肤更健康；酵母铬能够降低中性脂肪、协助胰岛素加速糖的代谢、增加重要的抗衰老荷尔蒙DHEA脱氢表雄酮来遏制衰老；均衡营养素蛋白质、维生素、矿物质、核酸等能够脂肪细胞排空的同时，迅速填入，充满营养素的细胞体积比充满脂肪的细胞体积要小得多，达到只减脂肪不减营养健康塑身效果。
而魔芋粉主要成分为魔芋葡甘聚糖，魔芋葡甘聚糖是一种多糖类可食半纤维，其吸水后体积会膨胀约80～100倍，因此人体摄入极少量魔芋葡甘聚糖即有饱胀感，并且魔芋葡甘聚糖不能被人体的酶消化，不提供养分，能够减缓胆固醇、糖分物质的吸收，具有润肠通便功效；蛋白粉优选为乳清蛋白与大豆蛋白，乳清蛋白与大豆蛋白均为优质蛋白质，含有人体所需的各种必需氨基酸。在饮食中，常常推荐植物蛋白与动物蛋白搭配食用，此外，乳清蛋白有助于降低超重者体重和餐后糖负荷，降低肥胖相关性疾病发生的风险。而大豆蛋白质则有助于降低血浆胆固醇含量，起到防止和减轻动物蛋白对肾脏损害的作用；所述抗性糊精能够提供膳食纤维，改善粘度。
维生素B1在体内转变成硫胺素焦磷酸(又称辅羧化酶)，参与糖在体内的代谢。添加维生素B1可帮助消化，特别是碳水化合物的消化；维生素B6既能参与蛋白质合成与分解代谢，参与所有氨基酸代谢，如与血红素的代谢有关，与色氨酸合成烟酸有关；又参与糖异生、UFA代谢，与糖原、神经鞘磷脂和类固醇的代谢有关；维生素 B12以辅酶的形式存在，可以增加叶酸的利用率，促进碳水化合物、脂肪和蛋白质的代谢，具有活化氨基酸的作用和促进核酸的生物合成，可促进蛋白质的合成，它对婴幼儿的生长发育有重要作用，代谢脂肪酸，使脂肪、碳水化合物、蛋白质被身体适当运用；烟酰胺在蛋白质和糖的新陈代谢中起作用，可改善人类和动物的营养；木糖醇为人体提供能量，合成糖元，减少脂肪和肝组织中的蛋白质的消耗，使肝脏受到保护和修复，减少人体内有害酮体的产生，不会因食用而为发胖忧虑。可广泛用于食品、医药、轻工等领域。木糖醇与普通的白砂糖相比，具有热量低的优势——每克木糖醇仅含有2.4卡路里热量，比其他大多数碳水化合物的热量少40％。
与现有技术相比，本发明取得了以下有益效果：本发明创新了食品的成分和配比，糖尿病患者在食用本配方食品后，在不改变饮食习惯的前提下，可以提供的充足蛋白质，保证机体的蛋白需求；同时，配方食品在饭前服用，可增加胰高血糖素样肽1和肠抑胃肽等肠道多肽的释放，延缓胃排空，增加饱腹感，降低食欲，控制体重；此外，本品丰富的膳食纤维和微量元素，加速脂肪代谢、排除肠道内的脂肪毒素，不仅可有助于维持胃肠道功能，也能够保证患者的营养平衡；配方食品还提供了适量的B族维生素，它可以有效地缓解糖尿病患者出现的周围神经病变；风味食品添加剂提升了食品食用时的体验，口感和味道都会改良；淀粉含量低、食用后饱腹感强、复合膳食同时有助于肠道健康的特点，有助于糖尿病患者的身体健康。
具体实施方式
如在说明书及权利要求当中使用了某些词汇来指称特定组件。本领域技术人员应可理解，硬件制造商可能会用不同名词来称呼同一个组件。本说明书及权利要求并不以名称的差异来作为区分组件的方式，而是以组件在功能上的差异来作为区分的准则。说明书后续描述为实施本申请的较佳实施方式，然所述描述乃以说明本申请的一般原则为目的，并非用以限定本申请的范围。本申请的保护范围当视所附权利要求所界定者为准。
以下对本申请作进一步详细说明，但不作为对本申请的限定。
实施例一：
一种供糖尿病患者食用的配方食品，其特征在于，包括8份魔芋粉、40份蛋白粉、24份啤酒酵母、6份抗性糊精、维生素B1、维生素B6、维生素B12、烟酰胺、木糖醇、麦香香精和三氯蔗糖，所述维生素B1、维生素B6、维生素B12和烟酰胺的分量分别为9mg/kg、 7mg/kg、10mg/kg和110ug/kg。
配方食品在饭前服用，可增加胰高血糖素样肽1和肠抑胃肽等肠道多肽的释放，延缓胃排空，增加饱腹感，降低食欲，控制体重。
实施例二：
一种供糖尿病患者食用的配方食品，其特征在于，包括10份魔芋粉、48份蛋白粉、28份啤酒酵母、8份抗性糊精、维生素B1、维生素B6、维生素B12、烟酰胺、木糖醇、麦香香精和三氯蔗糖，所述维生素B1、维生素B6、维生素B12和烟酰胺的分量分别为12 mg/kg、9mg/kg、14mg/kg和120ug/kg，配方食品在饭前服用。
实施例三：
一种供糖尿病患者食用的配方食品，其特征在于，包括11份魔芋粉、55份蛋白粉、35份啤酒酵母、12份抗性糊精、维生素B1、维生素B6、维生素B12、烟酰胺、木糖醇、麦香香精和三氯蔗糖，所述维生素B1、维生素B6、维生素B12和烟酰胺的分量分别为22 mg/kg、22mg/kg、66mg/kg和330ug/kg，配方食品在饭前服用。
上述实施例一至三的木糖醇、麦香香精和三氯蔗糖均可以根据相关标准和本领域常用量适量添加，此处不做限制与赘述。
上述实施例一至三的食品的GI数值检测数据结果显示，GI数值均低于55，其为低GI食物，适于糖尿病患者食用，且有助于提高糖尿病患者控制血糖的速度。
上述说明示出并描述了本申请的若干优选实施例，但如前所述，应当理解本申请并非局限于本文所披露的形式，不应看作是对其他实施例的排除，而可用于各种其他组合、修改和环境，并能够在本文所述申请构想范围内，通过上述教导或相关领域的技术或知识进行改动。而本领域人员所进行的改动和变化不脱离本申请的精神和范围，则都应在本申请所附权利要求的保护范围。
Claims (4)
1.一种供糖尿病患者食用的配方食品，其特征在于，包括8-11份魔芋粉、40-55份蛋白粉、24-35份啤酒酵母、6-12份抗性糊精和风味食品添加剂。
2.如权利要求1所述的一种供糖尿病患者食用的配方食品，其特征在于，还包括维生素B1、维生素B6、维生素B12和烟酰胺。
3.如权利要求2所述的一种供糖尿病患者食用的配方食品，其特征在于，所述维生素B1、维生素B6、维生素B12和烟酰胺的分量分别为9-22mg/kg、7-22mg/kg、10-66mg/kg和110-330mg/kg。
4.如权利要求3所述的一种供糖尿病患者食用的配方食品，其特征在于，所述风味食品添加剂包括木糖醇、麦香香精和三氯蔗糖。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710855446.6A CN107788451A (zh) | 2017-09-20 | 2017-09-20 | 一种供糖尿病患者食用的配方食品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710855446.6A CN107788451A (zh) | 2017-09-20 | 2017-09-20 | 一种供糖尿病患者食用的配方食品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107788451A true CN107788451A (zh) | 2018-03-13 |
Family
ID=61532172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710855446.6A Pending CN107788451A (zh) | 2017-09-20 | 2017-09-20 | 一种供糖尿病患者食用的配方食品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107788451A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109123414A (zh) * | 2018-09-10 | 2019-01-04 | 彭珊 | 一种胰岛素抵抗综合征人群的营养食品及其制备方法 |
| CN111066990A (zh) * | 2018-10-22 | 2020-04-28 | 山东瑞谱检测技术有限公司 | 一种含啤酒酵母粉的固体饮料及其制备方法 |
| CN112655977A (zh) * | 2021-01-04 | 2021-04-16 | 湖南慧泽生物医药科技有限公司 | 一种肥胖人群膳食营养补充剂 |
| CN112715930A (zh) * | 2021-01-04 | 2021-04-30 | 湖南慧泽生物医药科技有限公司 | 一种供糖尿病患者食用的配方食品 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000355539A (ja) * | 1999-06-10 | 2000-12-26 | Hiromu Kubota | 機能性結晶果糖複合剤の製造方法及び機能性結晶果糖複合剤 |
| CN106072533A (zh) * | 2016-06-18 | 2016-11-09 | 江苏阜丰生物科技有限公司 | 一种供糖尿病患者食用的全营养配方食品 |
| CN106798012A (zh) * | 2017-01-23 | 2017-06-06 | 长沙加生物科技有限公司 | 一种适用于ii型糖尿病人的功能性营养粉组合物 |
-
2017
- 2017-09-20 CN CN201710855446.6A patent/CN107788451A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000355539A (ja) * | 1999-06-10 | 2000-12-26 | Hiromu Kubota | 機能性結晶果糖複合剤の製造方法及び機能性結晶果糖複合剤 |
| CN106072533A (zh) * | 2016-06-18 | 2016-11-09 | 江苏阜丰生物科技有限公司 | 一种供糖尿病患者食用的全营养配方食品 |
| CN106798012A (zh) * | 2017-01-23 | 2017-06-06 | 长沙加生物科技有限公司 | 一种适用于ii型糖尿病人的功能性营养粉组合物 |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109123414A (zh) * | 2018-09-10 | 2019-01-04 | 彭珊 | 一种胰岛素抵抗综合征人群的营养食品及其制备方法 |
| CN111066990A (zh) * | 2018-10-22 | 2020-04-28 | 山东瑞谱检测技术有限公司 | 一种含啤酒酵母粉的固体饮料及其制备方法 |
| CN112655977A (zh) * | 2021-01-04 | 2021-04-16 | 湖南慧泽生物医药科技有限公司 | 一种肥胖人群膳食营养补充剂 |
| CN112715930A (zh) * | 2021-01-04 | 2021-04-30 | 湖南慧泽生物医药科技有限公司 | 一种供糖尿病患者食用的配方食品 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104432084B (zh) | 一种调理粉及其制备方法和用途 | |
| CN104431741B (zh) | 一种谷物调理粥及其制备方法和用途 | |
| CN102648717B (zh) | 一种营养面粉 | |
| CN103504305B (zh) | 一种具有降血糖功能的保健品及其制备方法 | |
| CN101564162B (zh) | 一种糖尿病人专用的保健主食面粉及其制备方法 | |
| CN107788451A (zh) | 一种供糖尿病患者食用的配方食品 | |
| CN102113648A (zh) | 一种适合“五高”代谢综合症人群的特膳面条及其制备方法 | |
| CN102715406A (zh) | 一种杂粮全营养食品及其制备方法 | |
| CN103168812A (zh) | 一种无蔗糖苦荞饼干及其制作方法 | |
| CN107373376A (zh) | 一种糖尿病营养配方米及其制备和烹制方法 | |
| CN101816317A (zh) | 一种具有降糖降脂功能的营养饼干 | |
| CN106135797A (zh) | 一种有助于调节血糖的营养组合物及其制备方法 | |
| CN109007856A (zh) | 一种适合高血压、高血脂、高血糖和高尿酸人群服用的代餐粉及制备方法 | |
| CN103371215B (zh) | 糖尿病人专用小麦糊粉层营养饼干及其制备方法 | |
| CN107094843A (zh) | 一种控血糖保健饼干及其制造方法 | |
| CN109549097A (zh) | 一种具有降糖降脂功能的保健面条 | |
| CN102113652A (zh) | 一种适合“五高”代谢综合症人群的特膳挤压米及其制备方法 | |
| CN108813590A (zh) | 一种适合糖尿病患者的低gi配方食品及其制备方法 | |
| CN101766297A (zh) | 一种糖尿病食疗面粉 | |
| CN105285644A (zh) | 一种富含膳食纤维的醋饮料及其制备方法 | |
| CN102987206A (zh) | 一种降糖组合物 | |
| CN110179061A (zh) | 分离牛奶蛋白营养餐 | |
| CN104366509A (zh) | 一种调节血糖的营养代餐粉及其制备方法 | |
| CN1857117A (zh) | 均衡人体能量代谢的复合粉 | |
| CN104872365A (zh) | 苦荞压片糖果及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180313 |